Thread: Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ib
View Single Post
Old 09-27-2018, 09:16 AM
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,272
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,272
15 yr Member
Post Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ib
Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ibudilast) in ALS
Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ibudilast) in ALS

ibudilast to phase III study. Full scale phase III studies tend to be the most expensive and the final testing phase before marketing. IF they pass.
MuonOne is offline   Reply With QuoteReply With Quote